Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Dose Escalation and Expanded Cohort Study of P-PSMA-101 in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04249947
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:50.822885+00:00
Published At
2025-02-17T00:00:00+00:00
Record Updated At
2025-02-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Prostatic Neoplasms, Castration-Resistant", "Neoplasms by Histologic Type", "Neoplasms, Prostate", "Prostate Cancer", "Metastatic Castration-resistant Prostate Cancer", "Neoplasms", "Prostatic Neoplasms", "Genital Neoplasms, Male", "Urogenital Neoplasms", "Neoplasms by Site", "Prostatic Disease", "Salivary Gland Cancer", "Salivary Gland Tumor", "Adenoid Cystic Carcinoma", "Salivary Duct Carcinoma", "Mucoepidermoid Carcinoma", "Acinic Cell Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-02-17"
protocolSection.identificationModule.nctId
"NCT04249947"
protocolSection.identificationModule.officialTitle
"A Phase 1 Dose Escalation and Expanded Cohort Study of P-PSMA-101 in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Prostatic Neoplasms, Castration-Resistant (protocolSection.conditionsModule.conditions)
  • Neoplasms by Histologic Type (protocolSection.conditionsModule.conditions)
  • Neoplasms, Prostate (protocolSection.conditionsModule.conditions)
  • Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Metastatic Castration-resistant Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Neoplasms (protocolSection.conditionsModule.conditions)
  • Prostatic Neoplasms (protocolSection.conditionsModule.conditions)
  • Genital Neoplasms, Male (protocolSection.conditionsModule.conditions)
  • Urogenital Neoplasms (protocolSection.conditionsModule.conditions)
  • Neoplasms by Site (protocolSection.conditionsModule.conditions)
  • Prostatic Disease (protocolSection.conditionsModule.conditions)
  • Salivary Gland Cancer (protocolSection.conditionsModule.conditions)
  • Salivary Gland Tumor (protocolSection.conditionsModule.conditions)
  • Adenoid Cystic Carcinoma (protocolSection.conditionsModule.conditions)
  • Salivary Duct Carcinoma (protocolSection.conditionsModule.conditions)
  • Mucoepidermoid Carcinoma (protocolSection.conditionsModule.conditions)
  • Acinic Cell Tumor (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.